Approved Treatments for COVID-19
- Name
- Approved Treatments for COVID-19
- Accession Number
- DBCAT005187
- Description
Treatments that have been approved for the indication of treating COVID-19 infections
- Drugs
Drug Drug Description Remdesivir A nucleoside analog used to treat RNA virus infections including COVID-19. Regdanvimab A monoclonal antibody targeted against the SARS-CoV-2 spike protein used to treat patients with COVID-19 who are at risk of progressing to severe COVID-19. Casirivimab Part of an investigational recombinant monoclonal antibody cocktail used to treat mild to moderate COVID-19. Imdevimab Part of an investigational recombinant monoclonal antibody cocktail used to treat mild to moderate COVID-19. Bebtelovimab A human IgG1κ monoclonal antibody targeted against the spike protein of SARS-CoV-2 which is used in the treatment of mild-to-moderate COVID-19. Sotrovimab A monoclonal antibody for the treatment of mild-to-moderate COVID-19 in patients at increased risk for death or hospitalization. - Drugs & Drug Targets